Inclusion Criteria:
  -  Patients older than 18 years (of both sexes) diagnosed with rheumatoid arthritis according to ACR / EULAR 2010 criteria .
  -  Patients with moderate to high disease activity (DAS - 28 . score greater than 3.2)
  -  Patients received the standard therapy (i.e. one or more conventional DMARDs) for at least three months.
Exclusion Criteria:
  -  Known hypersensitivity to metformin.
  -  Patients who have a prior diagnosis with diabetes mellitus.
  -  Patients receive metformin for any other indications.
  -  Patients with congestive heart failure.
  -  Patients with a history of myocardial infarction.
  -  Patients with severe anemia.
  -  Patients with active infections or other inflammatory diseases.
  -  Patients receiving biological therapy.
  -  Pregnancy or lactation.
  -  Patients with impaired liver functions.
  -  Patients with impaired kidney functions (serum creatinine concentrations ≥1.5 and ≥1.4 mg/dL in males and females respectively).
  -  Patients with malignancies.